Pharmafile Logo

Peter Impey

- PMLiVE

Italian CRO Cromsource expands into France

New Paris office will be led by Christian Milla

- PMLiVE

Novo backs Victoza’s prospects in Alzheimer’s

Chief science officer says phase III trial could begin in three years

Shrinkwrapping, ROI and social etiquette

Why being fashionably late is not a bad option and what pharma digital can learn from consumer

- PMLiVE

Hospira CEO joins board of Kythera

Michael Ball named director of aesthetic medicine specialist

- PMLiVE

US shutdown threatens to disrupt FDA

Congress failure to agree budget cripples government functions

- PMLiVE

Lundbeck buoyed by Brintellix approval in US

FDA gives green light for to Cipralex/Lexapro successor in depression

- PMLiVE

Lundbeck presses on with cost-saving programme

Will cut up to 200 business services jobs in Europe

- PMLiVE

FDA gives green light to Roche for early Perjeta in breast cancer

Oncology drug can now be used before surgery in the US

- PMLiVE

GSK sells off anticoagulants for £700m

South Africa-based Aspen buys rights to Arixtra and Fraxiparine

- PMLiVE

Industry veteran Louis Nisbet joins Sygnature board

Brings experience from Roche, Glaxo and SmithKline

- PMLiVE

Ogilvy PR adds to senior health team

Three of the New York office’s six new hires have been recruited to the healthcare team

- PMLiVE

Intermune supports awareness efforts for IPF

Last week's IPF World Week saw the global patient community unite

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links